Do you continue ovarian suppression for metastatic hormone-positive breast cancer patients who are premenopausal, regardless of line of therapy?  

I continue OFS while a patient is on an endocrine therapy, but discontinue OFS if the patient demonstrates resistance to endocrine therapies and transitions to chemotherapy, which typically suppresses ovarian function anyway.